IRIS
BURONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.468
AS - Asia 2.680
EU - Europa 2.307
SA - Sud America 427
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 126
OC - Oceania 15
AN - Antartide 1
Totale 10.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.254
CN - Cina 1.211
SG - Singapore 577
IE - Irlanda 494
IT - Italia 342
BR - Brasile 321
HK - Hong Kong 308
RU - Federazione Russa 282
DE - Germania 253
VN - Vietnam 237
UA - Ucraina 217
FI - Finlandia 199
FR - Francia 138
GB - Regno Unito 137
SE - Svezia 105
CA - Canada 94
IN - India 70
ZA - Sudafrica 59
BD - Bangladesh 56
AR - Argentina 40
JP - Giappone 32
MX - Messico 31
IQ - Iraq 26
PL - Polonia 23
JO - Giordania 22
ES - Italia 20
TR - Turchia 19
CO - Colombia 18
ID - Indonesia 17
NL - Olanda 15
BE - Belgio 14
CR - Costa Rica 14
EC - Ecuador 13
IL - Israele 13
AU - Australia 12
LT - Lituania 12
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
EG - Egitto 11
GT - Guatemala 11
HN - Honduras 11
AT - Austria 10
JM - Giamaica 10
PK - Pakistan 10
TT - Trinidad e Tobago 10
UZ - Uzbekistan 10
CL - Cile 9
MA - Marocco 9
NG - Nigeria 9
SC - Seychelles 8
PH - Filippine 7
SV - El Salvador 7
VE - Venezuela 7
BO - Bolivia 6
GR - Grecia 6
KG - Kirghizistan 6
PE - Perù 6
PR - Porto Rico 6
PY - Paraguay 6
SA - Arabia Saudita 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
CW - ???statistics.table.value.countryCode.CW??? 5
DO - Repubblica Dominicana 5
KE - Kenya 5
MU - Mauritius 5
MY - Malesia 5
NP - Nepal 5
TH - Thailandia 5
CH - Svizzera 4
HU - Ungheria 4
NI - Nicaragua 4
PA - Panama 4
DK - Danimarca 3
ET - Etiopia 3
GP - Guadalupe 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
CG - Congo 2
DZ - Algeria 2
EU - Europa 2
IR - Iran 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
ZM - Zambia 2
AI - Anguilla 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
Totale 10.015
Salva come PNG Salva come JPEG
Città #
Chandler 489
Dublin 485
San Jose 432
Ashburn 425
Singapore 330
Hong Kong 303
Beijing 298
Dallas 260
Jacksonville 258
Nanjing 194
Council Bluffs 192
Boardman 144
Los Angeles 105
Ho Chi Minh City 91
Helsinki 86
Lauterbourg 85
Princeton 82
Lawrence 75
Pavia 69
Nanchang 68
Wilmington 68
New York 66
Medford 64
Ann Arbor 63
Jiaxing 63
Munich 61
Shenyang 59
Hanoi 58
Shanghai 56
Changsha 55
Hebei 53
Johannesburg 52
Santa Clara 52
Moscow 46
Hangzhou 42
Buffalo 41
Milan 40
Tianjin 33
São Paulo 30
Tokyo 29
Redondo Beach 28
Frankfurt am Main 26
Brooklyn 24
Rome 23
San Francisco 22
The Dalles 22
Woodbridge 22
Amman 21
Denver 21
Montreal 21
Orem 21
Toronto 21
Houston 20
Boston 19
Columbus 19
London 18
Turku 18
Warsaw 18
Norwalk 16
Chicago 15
Phoenix 15
Stockholm 15
Atlanta 14
Da Nang 14
Naples 14
Seattle 14
Verona 14
Brussels 13
Mexico City 13
Poplar 13
Washington 13
Brasília 12
Mumbai 12
Ottawa 12
Baku 11
Falkenstein 11
Florence 11
Rio de Janeiro 11
Baghdad 10
Falls Church 10
Guatemala City 10
Manchester 10
Nuremberg 10
Olomouc 10
Porto Alegre 10
Tashkent 10
Fairfield 9
Haiphong 9
Hyderabad 9
Hải Dương 9
Lagos 9
Piscataway 9
San José 9
Chennai 8
Redwood City 8
Vienna 8
Amsterdam 7
Curitiba 7
Des Moines 7
St Petersburg 7
Totale 6.344
Salva come PNG Salva come JPEG
Nome #
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase DprE1. 191
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 179
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 177
Antistaphylococcal activity of the ftsz inhibitor c109 177
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii 174
Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study 170
A census of RND superfamily proteins in the Burkholderia genus. 166
Analyzing the role of RND efflux transporters in Burkholderia cenocepacia: a proteomic analysis. 161
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 160
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 160
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 160
Differential role of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells 155
Decaprenylphosphoryl-β-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target 153
Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections 149
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems. 145
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 141
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 141
Characterization of the mechanism of resistance to BM212, a new potential antitubercular drug. 140
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 140
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. 140
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 139
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 139
Bombas de eflujo como trasportadores de membrana implicados en resistencia a antibióticos en micobacterias 136
Identification and characterization of the cellular target for benzothiazinones, a new potential antitubercular drug class. 136
Molecular characterization of the burkholderia cenocepacia dcw operon and ftsz interactors as new targets for novel antimicrobial design 134
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 133
A new promising bactericidal compound against Burkholderia cenocepacia. 131
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 131
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 130
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia. 129
Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against Pseudomonas aeruginosa 128
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. 128
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 127
Espressione, purificazione ed analisi funzionale della NAD+ sintetasi di Mycobacterium tuberculosis, un enzima essenziale 127
Study of the regulation of lfrA gene coding for an antibiotic efflux pump of Mycobacterium smegmatis. 126
Burkholderia cenocepacia infections in cystic fibrosis patients: Drug resistance and therapeutic approaches 125
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 125
Contribution of the Mycobacterium tuberculosis efflux pumps to drug resistance 124
Antimicrobial activity of six essential oils against Burkholderia cepacia complex: Insights into mechanism(s) of action 123
Identification of a New FtsZ Inhibitor by Virtual Screening, Mechanistic Insights, and Structure-Activity Relationship Analyses 122
AI is a viable alternative to high throughput screening: a 318-target study 121
CodY Is a Global Transcriptional Regulator Required for Virulence in Group B Streptococcus 120
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug. 119
Methodological tools to study species of the genus Burkholderia 119
Studies on the identification and characterization of the cellular target of the potential antitubercular drug BM212. 117
Mycobacterium tuberculosis: drug resistance and future perspectives 117
Role in benzothiazinone resistance of nitroreductase NfnB of Mycobacterium smegmatis 115
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 115
The crystal structure of Burkholderia cenocepacia DfsA provides insights into substrate recognition and quorum sensing fatty acid biosynthesis 115
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 113
Identification of the cellular target of the potential antitubercular drug BM 212 112
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. 112
Antivirulence compounds: a future direction to overcome antibiotic resistance? 107
The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It 105
Role of rnd efflux pumps in drug resistance of cystic fibrosis pathogens 105
Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia. 104
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain. 104
Rv3790 is the cellular target for benzothiazinones, a new promising antitubercular drug class 103
Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens 100
Fighting against resistant strains: the case of benzothiazinones and dinitrobenzamides 99
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 98
Study of antibiotic efflux pumps belonging to Resistance-Nodulation-Division (RND) family in Burkholderia cenocepacia. 94
New antivirulence compounds affecting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 94
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia 93
The role of RND efflux transporters in intrinsic antibiotic resistance of Burkholderia cenocepacia 91
Molecular basis for antibiotic resistance in the genus Burkholderia 91
Illumina-based chemogenomic profiling of a novel compound with antimicrobial activity reveals its role as a cell division inhibitor. 91
Quorum sensing as antivirulence target in cystic fibrosis pathogens 91
Antibiotics sustainability: another issue in the fight against antimicrobial resistance. 90
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa MDR clinical isolates. 89
Recent advances to combat ESKAPE pathogens with special reference to essential oils 88
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 83
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis 81
Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. 81
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 81
Mycobacterium tuberculosis efflux pumps: an update 78
THERAPEUTIC STRATEGIES TO COMBAT STAPHYLOCOCCUS AUREUS INFECTIONS IN CYSTIC FIBROSIS 73
The role of RND efflux transporters in Burkholderia cenocepacia life. 72
Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the quorum sensing inhibitor baicalin hydrate in Burkholderia cenocepacia biofilms 71
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 69
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact 69
Phenylacetyl-CoA, not phenylacetic acid, attenuates CepIR-regulated virulence in Burkholderia cenocepacia 69
Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance 60
Editorial: Community series in insights into new strategies to combat biofilms, volume II 54
Lessons from Vibrio Pathogen and the Comparative Study of Vaccines Developed 50
Editorial: Burkholderia spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment 48
Editorial: Insights Into New Strategies to Combat Biofilms 46
Editorial: Evolution of Genetic Mechanisms of Antibiotic Resistance 43
Liposomal tobramycin and ceftazidime as advanced nanocarriers against Pseudomonas aeruginosa infections 40
Synthesis, structural characterization, and biological evaluation of cinnamaldehyde–azomethine hybrids: In Vitro and In Silico approaches 40
Totale 10.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.928
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022332 0 0 0 0 11 12 9 20 18 11 57 194
2022/20231.329 127 113 12 125 126 119 12 83 557 7 29 19
2023/2024569 62 89 19 30 40 119 26 60 5 40 46 33
2024/20251.533 23 101 44 32 64 87 116 94 384 65 196 327
2025/20263.534 301 201 406 389 498 153 617 155 334 236 156 88
2026/20271.005 60 164 213 382 186 0 0 0 0 0 0 0
Totale 10.212